PDB Short entry for 1JDN HEADER SIGNALING PROTEIN 14-JUN-01 1JDN TITLE CRYSTAL STRUCTURE OF HORMONE RECEPTOR CAVEAT 1JDN NAG B 1 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ATRIAL NATRIURETIC PEPTIDE CLEARANCE RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NPR-C; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: S2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRMHA3 KEYWDS NATRIURETIC PEPTIDE RECEPTOR, DIMER, ALLOSTERIC ACTIVATION, SIGNALING KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR X.-L.HE,D.-C.CHOW,M.M.MARTICK,K.C.GARCIA REVDAT 6 03-APR-24 1JDN 1 HETSYN REVDAT 5 29-JUL-20 1JDN 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 13-JUL-11 1JDN 1 VERSN REVDAT 3 24-FEB-09 1JDN 1 VERSN REVDAT 2 01-APR-03 1JDN 1 JRNL REVDAT 1 05-SEP-01 1JDN 0 JRNL AUTH X.L.HE,D.C.CHOW,M.M.MARTICK,K.C.GARCIA JRNL TITL ALLOSTERIC ACTIVATION OF A SPRING-LOADED NATRIURETIC PEPTIDE JRNL TITL 2 RECEPTOR DIMER BY HORMONE. JRNL REF SCIENCE V. 293 1657 2001 JRNL REFN ISSN 0036-8075 JRNL PMID 11533490 JRNL DOI 10.1126/SCIENCE.1062246 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 43722 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.243 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2180 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3670 REMARK 3 BIN FREE R VALUE : 0.3890 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 170 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3230 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 134 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 86.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.15000 REMARK 3 B22 (A**2) : 12.15000 REMARK 3 B33 (A**2) : -24.30000 REMARK 3 B12 (A**2) : 13.77000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM SIGMAA (A) : 0.65 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.66 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JDN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-JUN-01. REMARK 100 THE DEPOSITION ID IS D_1000013657. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JAN-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43722 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.98400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: THE COMPLEX OF THIS RECEPTOR WITH HORMONE BEING REMARK 200 PROCESSED PRESENTLY. REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: POTASSIUM SODIUM PHOSPHATE, LITHIUM REMARK 280 CHLORIDE, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.59767 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.19533 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 65.39650 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 108.99417 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 21.79883 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 43.59767 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 87.19533 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 108.99417 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 65.39650 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 21.79883 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE SECOND PART OF THE BIOLOGICAL ASSEMBLY IS GENERATED REMARK 300 BY THE TWO FOLD AXIS: -Y, -X, -Z+5/6. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 -0.866025 0.000000 108.59450 REMARK 350 BIOMT2 2 -0.866025 -0.500000 0.000000 188.09119 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 108.99417 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A -1 REMARK 465 ARG A 0 REMARK 465 GLU A 1 REMARK 465 ALA A 2 REMARK 465 LEU A 3 REMARK 465 PRO A 4 REMARK 465 ASN A 41 REMARK 465 GLY A 42 REMARK 465 THR A 43 REMARK 465 GLY A 44 REMARK 465 ARG A 45 REMARK 465 ARG A 46 REMARK 465 LEU A 47 REMARK 465 ILE A 419 REMARK 465 VAL A 420 REMARK 465 GLU A 421 REMARK 465 HIS A 422 REMARK 465 THR A 423 REMARK 465 ASN A 424 REMARK 465 SER A 425 REMARK 465 SER A 426 REMARK 465 PRO A 427 REMARK 465 CYS A 428 REMARK 465 LYS A 429 REMARK 465 SER A 430 REMARK 465 CYS A 431 REMARK 465 GLY A 432 REMARK 465 LEU A 433 REMARK 465 GLU A 434 REMARK 465 GLU A 435 REMARK 465 SER A 436 REMARK 465 ALA A 437 REMARK 465 VAL A 438 REMARK 465 THR A 439 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLN A 346 NH1 ARG A 350 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 303 N - CA - C ANGL. DEV. = -16.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 49 -168.23 -65.71 REMARK 500 PRO A 50 -87.66 -63.28 REMARK 500 ASP A 62 15.38 59.70 REMARK 500 ASP A 106 55.23 33.72 REMARK 500 PHE A 119 7.98 -66.48 REMARK 500 SER A 124 -90.64 -166.32 REMARK 500 SER A 153 2.44 -156.44 REMARK 500 LYS A 163 37.34 71.31 REMARK 500 LEU A 164 -105.82 -148.35 REMARK 500 PHE A 191 149.02 176.39 REMARK 500 ASP A 198 46.28 -92.66 REMARK 500 SER A 209 -66.88 -106.93 REMARK 500 ASN A 248 48.99 30.84 REMARK 500 ARG A 259 -36.04 -145.56 REMARK 500 LEU A 280 128.75 -38.44 REMARK 500 GLN A 301 40.57 -90.84 REMARK 500 LEU A 303 134.46 175.74 REMARK 500 GLU A 306 -167.73 75.99 REMARK 500 LYS A 337 -3.74 -58.09 REMARK 500 GLU A 385 141.21 -172.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JDP RELATED DB: PDB REMARK 900 1JDP CONTAINS THE LIGANDED RECEPTOR. DBREF 1JDN A -1 439 UNP P17342 ANPC_HUMAN 44 484 SEQRES 1 A 441 GLU ARG GLU ALA LEU PRO PRO GLN LYS ILE GLU VAL LEU SEQRES 2 A 441 VAL LEU LEU PRO GLN ASP ASP SER TYR LEU PHE SER LEU SEQRES 3 A 441 THR ARG VAL ARG PRO ALA ILE GLU TYR ALA LEU ARG SER SEQRES 4 A 441 VAL GLU GLY ASN GLY THR GLY ARG ARG LEU LEU PRO PRO SEQRES 5 A 441 GLY THR ARG PHE GLN VAL ALA TYR GLU ASP SER ASP CYS SEQRES 6 A 441 GLY ASN ARG ALA LEU PHE SER LEU VAL ASP ARG VAL ALA SEQRES 7 A 441 ALA ALA ARG GLY ALA LYS PRO ASP LEU ILE LEU GLY PRO SEQRES 8 A 441 VAL CYS GLU TYR ALA ALA ALA PRO VAL ALA ARG LEU ALA SEQRES 9 A 441 SER HIS TRP ASP LEU PRO MET LEU SER ALA GLY ALA LEU SEQRES 10 A 441 ALA ALA GLY PHE GLN HIS LYS ASP SER GLU TYR SER HIS SEQRES 11 A 441 LEU THR ARG VAL ALA PRO ALA TYR ALA LYS MET GLY GLU SEQRES 12 A 441 MET MET LEU ALA LEU PHE ARG HIS HIS HIS TRP SER ARG SEQRES 13 A 441 ALA ALA LEU VAL TYR SER ASP ASP LYS LEU GLU ARG ASN SEQRES 14 A 441 CYS TYR PHE THR LEU GLU GLY VAL HIS GLU VAL PHE GLN SEQRES 15 A 441 GLU GLU GLY LEU HIS THR SER ILE TYR SER PHE ASP GLU SEQRES 16 A 441 THR LYS ASP LEU ASP LEU GLU ASP ILE VAL ARG ASN ILE SEQRES 17 A 441 GLN ALA SER GLU ARG VAL VAL ILE MET CYS ALA SER SER SEQRES 18 A 441 ASP THR ILE ARG SER ILE MET LEU VAL ALA HIS ARG HIS SEQRES 19 A 441 GLY MET THR SER GLY ASP TYR ALA PHE PHE ASN ILE GLU SEQRES 20 A 441 LEU PHE ASN SER SER SER TYR GLY ASP GLY SER TRP LYS SEQRES 21 A 441 ARG GLY ASP LYS HIS ASP PHE GLU ALA LYS GLN ALA TYR SEQRES 22 A 441 SER SER LEU GLN THR VAL THR LEU LEU ARG THR VAL LYS SEQRES 23 A 441 PRO GLU PHE GLU LYS PHE SER MET GLU VAL LYS SER SER SEQRES 24 A 441 VAL GLU LYS GLN GLY LEU ASN MET GLU ASP TYR VAL ASN SEQRES 25 A 441 MET PHE VAL GLU GLY PHE HIS ASP ALA ILE LEU LEU TYR SEQRES 26 A 441 VAL LEU ALA LEU HIS GLU VAL LEU ARG ALA GLY TYR SER SEQRES 27 A 441 LYS LYS ASP GLY GLY LYS ILE ILE GLN GLN THR TRP ASN SEQRES 28 A 441 ARG THR PHE GLU GLY ILE ALA GLY GLN VAL SER ILE ASP SEQRES 29 A 441 ALA ASN GLY ASP ARG TYR GLY ASP PHE SER VAL ILE ALA SEQRES 30 A 441 MET THR ASP VAL GLU ALA GLY THR GLN GLU VAL ILE GLY SEQRES 31 A 441 ASP TYR PHE GLY LYS GLU GLY ARG PHE GLU MET ARG PRO SEQRES 32 A 441 ASN VAL LYS TYR PRO TRP GLY PRO LEU LYS LEU ARG ILE SEQRES 33 A 441 ASP GLU ASN ARG ILE VAL GLU HIS THR ASN SER SER PRO SEQRES 34 A 441 CYS LYS SER CYS GLY LEU GLU GLU SER ALA VAL THR MODRES 1JDN ASN A 248 ASN GLYCOSYLATION SITE MODRES 1JDN ASN A 349 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NDG B 2 14 HET BMA B 3 11 HET MAN B 4 11 HET BMA B 5 11 HET BMA B 6 11 HET NAG C 1 14 HET NAG C 2 14 HET MAN C 3 11 HET BMA C 4 11 HET FUC C 5 10 HET CL A 451 1 HET CL A 452 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 2 NDG C8 H15 N O6 FORMUL 2 BMA 4(C6 H12 O6) FORMUL 2 MAN 2(C6 H12 O6) FORMUL 3 FUC C6 H12 O5 FORMUL 4 CL 2(CL 1-) HELIX 1 1 SER A 23 GLU A 39 1 17 HELIX 2 2 ASN A 65 ALA A 78 1 14 HELIX 3 3 CYS A 91 TRP A 105 1 15 HELIX 4 4 ALA A 116 HIS A 121 5 6 HELIX 5 5 TYR A 136 HIS A 150 1 15 HELIX 6 6 ARG A 166 GLY A 183 1 18 HELIX 7 7 ASP A 198 ALA A 208 1 11 HELIX 8 8 SER A 218 HIS A 232 1 15 HELIX 9 9 LEU A 246 GLY A 253 5 8 HELIX 10 10 HIS A 263 TYR A 271 1 9 HELIX 11 11 LYS A 284 GLN A 301 1 18 HELIX 12 12 ASN A 310 ARG A 332 1 23 HELIX 13 13 ASP A 339 TRP A 348 1 10 HELIX 14 14 GLY A 408 LEU A 412 5 5 SHEET 1 A 5 PHE A 54 ASP A 60 0 SHEET 2 A 5 ILE A 8 LEU A 14 1 O ILE A 8 N GLN A 55 SHEET 3 A 5 LEU A 85 LEU A 87 1 O LEU A 85 N LEU A 11 SHEET 4 A 5 MET A 109 SER A 111 1 N LEU A 110 O ILE A 86 SHEET 5 A 5 LEU A 129 ARG A 131 1 O THR A 130 N SER A 111 SHEET 1 B 8 HIS A 185 PHE A 191 0 SHEET 2 B 8 ARG A 154 SER A 160 1 O ALA A 155 N SER A 187 SHEET 3 B 8 VAL A 212 CYS A 216 1 O VAL A 212 N ALA A 156 SHEET 4 B 8 ALA A 240 ILE A 244 1 O ALA A 240 N VAL A 213 SHEET 5 B 8 LEU A 274 LEU A 279 1 N GLN A 275 O PHE A 241 SHEET 6 B 8 ASP A 370 ASP A 378 -1 N SER A 372 O THR A 278 SHEET 7 B 8 THR A 383 PHE A 391 -1 O THR A 383 N THR A 377 SHEET 8 B 8 ARG A 396 MET A 399 -1 O ARG A 396 N PHE A 391 SHEET 1 C 2 ARG A 350 GLY A 354 0 SHEET 2 C 2 GLY A 357 ILE A 361 -1 O GLY A 357 N GLY A 354 SSBOND 1 CYS A 63 CYS A 91 1555 1555 2.04 SSBOND 2 CYS A 168 CYS A 216 1555 1555 2.06 LINK ND2 ASN A 248 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN A 349 C1 NAG C 1 1555 1555 1.45 LINK O4 NAG B 1 C1 NDG B 2 1555 1555 1.40 LINK O4 NDG B 2 C1 BMA B 3 1555 1555 1.39 LINK O4 BMA B 3 C1 MAN B 4 1555 1555 1.40 LINK O6 BMA B 3 C1 BMA B 6 1555 1555 1.42 LINK O4 MAN B 4 C1 BMA B 5 1555 1555 1.40 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O6 NAG C 1 C1 FUC C 5 1555 1555 1.42 LINK O4 NAG C 2 C1 MAN C 3 1555 1555 1.39 LINK O4 MAN C 3 C1 BMA C 4 1555 1555 1.40 CISPEP 1 GLY A 88 PRO A 89 0 -0.18 CRYST1 217.189 217.189 130.793 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004604 0.002658 0.000000 0.00000 SCALE2 0.000000 0.005317 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007646 0.00000